Agios Pharmaceuticals, Inc. (AGIO) Backed by TD Cowen for Mitapivat’s Market Potential

finance.yahoo.com/news/agios-pharmaceuticals-inc-agio-backed-173745931.html

In This Article:
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is among the best NASDAQ stocks under $50 to buy. On Monday, analysts at TD Cowen reaffirmed their Buy rating on Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), expressing confidence in the company’s mitapivat drug ahead of trial…

This story appeared on finance.yahoo.com, 2025-06-17 17:37:45.
The Entire Business World on a Single Page. Free to Use →